Aprepitant for gefitinib-induced refractory pruritus in Chinese malignancy population-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aprepitant for gefitinib-induced refractory pruritus in Chinese malignancy population

Published:2019-02 Issue:3 Volume:7 Page:54-54
ISSN:2305-5839
Container-title:Annals of Translational Medicine
language:
Short-container-title:Ann. Transl. Med

Author:

Qin Haifeng,Wang Fang,Wang Ke,Liu Hui,Guo Rui,Zeng Zhen,Pan Xin,Fu Xiaofeng,Zhang Ting,Gao Hongjun

Publisher

AME Publishing Company

Subject

General Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus of the Taiwanese dermatological association and Taiwan Lung Cancer Society on the prevention and management of tyrosine kinase inhibitor-related skin toxicities in patients with non-small cell lung cancer: An updated version incorporating Taiwanese treatment experience;Journal of the Formosan Medical Association;2024-08

2. Flagellate-like presentation of Stevens-Johnson syndrome: Toxic epidermal necrolysis after gefitinib therapy;Indian Journal of Dermatology, Venereology and Leprology;2024-06-27

3. Comparison of aprepitant versus desloratadine for EGFR‐TKI‐induced pruritus: A randomized phase 2 clinical trial;Cancer;2022-10-05

4. Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial;BMJ Open;2020-02

5. EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION AND ACQUIRED RESISTANCE TO GEFITINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER;ACTA MEDICA MEDITERR;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP